skip to Main Content
Can Baby Aspirin Lower Cancer Risk?

Can Baby Aspirin Lower Cancer Risk?

Recent studies have shown that taking a low dose of aspirin every day can be effective in preventing certain types of cancer, including colorectal, melanoma, and pancreatic. The recommended dosage is 81 milligrams a day, or one baby aspirin. Daily use of low-dose aspirin has been most beneficial in the prevention of colorectal cancer. 

How does aspirin prevent cancer?

In order for cancer to spread rapidly, it must first invade the bloodstream. Cancer cells may attach to platelets to travel through the body and leave blood vessels without being recognized by white blood cells. The molecules on platelets called integrins may allow the cancer cells to attach to the platelet and travel through the bloodstream.

Normally, cancer cells would be identified as invaders in the bloodstream, and white blood cells would destroy them. However, when attached to platelets, the white blood cells assume that it is just a platelet travelling through the bloodstream because they are unable to properly identify them as cancer cells.

Aspirin can play an essential role in cancer prevention because it inhibits the activation of platelets that allows cancer cells to bond to them. Platelet activation is essential for the survival of cancer cells in the bloodstream. When a platelet is inhibited, it makes it difficult for the cancer cells to attach to the platelet and prevents them from spreading rapidly. Cancer cells in the bloodstream that are not attached to platelets are easily identifiable, and the white blood cells will work to destroy them. Aspirin inhibiting platelet activation prevents cancer cells from going unnoticed in the bloodstream and allows the body to take action before the cancer can spread.

Aspirin has anti-inflammatory properties that aid in cancer prevention. Aspirin triggers inflammatory enzymes to stop producing molecules that generate inflammation and start using omega-3 fatty acids to produce anti-inflammatory agents, like Resolvin D3. Most digestive tract cancers are associated with high levels of inflammation. Since aspirin reduces inflammation, it also reduces the risk of developing these types of cancers.

Who should take aspirin daily?

Individuals between 50 and 65 years may benefit from taking a small dose of aspirin daily to prevent cancer, stroke, and heart disease. Taking aspirin daily over the age of 70 may increase the risk of bleeding. If you are considering taking aspirin daily to prevent cancer, speak with your trusted physician to see if it is right for you. 

Aspirin use in cancer treatment

While aspirin can serve to prevent cancer, it may also be used to treat cancer as well. Here at UNIFONTIS, we have an innovative treatment involving aspirin and diflunisal combination therapy. Aspirin and diflunisal work together to induce pore-formation and apoptosis (programmed cell death) in cancer cells. The treatment is able to shrink tumors and kill cancer cells without causing any damage to healthy organs.

Aspirin and diflunisal are pH-sensitive because they are derived from salicylic acid. Cancer cells are more acidic than the body’s healthy tissue. The pH-sensitivity allows aspirin and diflunisal to identify and attack the acidic cancer cells. Because they do not attack any healthy tissue in the body, this treatment is a safe way to fight cancer. 

The aspirin and diflunisal treatment is administered through IV infusion. Aspirin is injected into the bloodstream first. Once it has entered the bloodstream, the aspirin is able to capture all of the albumin proteins so that they do not saturate and block the diflunisal. The diflunisal is finally administered and is able to travel through the tissues and kill cancer cells.

To schedule a consultation with the medical director at UNIFONTIS, email us at info@unifontis.net.

Back To Top